Quest Diagnostics (DGX)
Provides clinical testing, pathology, and laboratory services through a North American network.
$237.42
vs last close+2.66 (+1.13%)
Something off on this page? Send us feedback.
Next report
Oct 22, 26
in 29 days
EPS estimate
$2.85
Revenue estimate
$3.04B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$2.23$2.21$2.62$2.60$2.42$2.50$3.12Pending
Estimate$2.19$2.15$2.57$2.50$2.36$2.37$2.82$2.85
Surprise+1.8%+2.8%+1.9%+4.0%+2.5%+5.5%+10.6%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$2.62B$2.65B$2.76B$2.82B$2.81B$2.90B$3.04BPending
Estimate$2.58B$2.63B$2.73B$2.74B$2.75B$2.83B$2.97B$3.04B
Surprise+1.6%+0.8%+1.3%+2.9%+1.9%+2.3%+2.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $3.13 | — | — |
| Sep 2028 | $3.26 | — | — |
| Jun 2028 | $3.32 | — | — |
| Mar 2028 | $3.09 | — | — |
| Dec 2027 | $2.95 | — | — |
| Sep 2027 | $3.12 | — | — |
| Jun 2027 | $3.15 | — | — |
| Mar 2027 | $2.78 | — | — |
| Dec 2026 | $2.68 | — | — |
| Oct 2026 | $2.85 | — | — |
| Jul 2026 | $2.82 | $3.12 | +10.6% |
| Apr 2026 | $2.37 | $2.50 | +5.5% |
| Feb 2026 | $2.36 | $2.42 | +2.5% |
| Oct 2025 | $2.50 | $2.60 | +4.0% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $3.13 | — | — | $3.28B | — | — | — |
| Sep 2028 | $3.26 | — | — | $3.31B | — | — | — |
| Jun 2028 | $3.32 | — | — | $3.30B | — | — | — |
| Mar 2028 | $3.09 | — | — | $3.18B | — | — | — |
| Dec 2027 | $2.95 | — | — | $3.15B | — | — | — |
| Sep 2027 | $3.12 | — | — | $3.19B | — | — | — |
| Jun 2027 | $3.15 | — | — | $3.18B | — | — | — |
| Mar 2027 | $2.78 | — | — | $3.03B | — | — | — |
| Dec 2026 | $2.68 | — | — | $3.01B | — | — | — |
| Oct 20, 2026 | $2.85 | — | — | $3.04B | — | — | — |
| Jul 23, 2026 | $2.82 | $3.12 | +10.6% | $2.97B | $3.04B | +2.4% | +8.6% |
| Apr 21, 2026 | $2.37 | $2.50 | +5.5% | $2.83B | $2.90B | +2.3% | +4.5% |
| Feb 10, 2026 | $2.36 | $2.42 | +2.5% | $2.75B | $2.81B | +1.9% | +7.4% |
| Oct 21, 2025 | $2.50 | $2.60 | +4.0% | $2.74B | $2.82B | +2.9% | −3.0% |
| Jul 22, 2025 | |||||||
| Apr 22, 2025 | |||||||
| Jan 30, 2025 | |||||||
| Oct 22, 2024 | |||||||
| Jul 23, 2024 | |||||||
| Apr 23, 2024 | |||||||
| Feb 1, 2024 | |||||||
| Oct 24, 2023 | |||||||
| Jul 26, 2023 | |||||||
| Apr 27, 2023 | |||||||
| Feb 2, 2023 | |||||||
| Oct 20, 2022 | |||||||
| Jul 21, 2022 | |||||||
| Apr 21, 2022 | |||||||
| Feb 3, 2022 | |||||||
| Oct 21, 2021 | |||||||
| Jul 22, 2021 | |||||||
| Apr 22, 2021 | |||||||
| Feb 4, 2021 | |||||||
| Oct 22, 2020 | |||||||
| Jul 23, 2020 | |||||||
| Apr 22, 2020 | |||||||
| Jan 30, 2020 | |||||||
| Oct 22, 2019 | |||||||
| Jul 23, 2019 | |||||||
| Apr 23, 2019 | |||||||
| Feb 14, 2019 | |||||||
| Oct 23, 2018 | |||||||
| Jul 24, 2018 | |||||||
| Apr 19, 2018 | |||||||
| Feb 1, 2018 | |||||||
| Oct 19, 2017 | |||||||
| Jul 25, 2017 | |||||||
| Apr 20, 2017 | |||||||
| Jan 26, 2017 | |||||||
| Oct 20, 2016 | |||||||
| Jul 21, 2016 | |||||||
| Apr 21, 2016 | |||||||
| Jan 28, 2016 | |||||||
| Oct 22, 2015 | |||||||
| Jul 23, 2015 |